Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

Completed · Phase 3 · Has a placebo group

Conditions studied: Scalp Psoriasis

In brief

A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS topical product in Patients with Mild to Severe Scalp Psoriasis

Key facts

Study ID

NCT02933866

Run by

Sun Pharmaceutical Industries, Inc.

People needed

371

Starts

2016-03-11

Expected to finish

2017-09-29

Last updated by the study team

2018-12-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or non-pregnant, non-lactating females 18 years of age and older.

You may not qualify if…

• Females who are pregnant, lactating or likely to become pregnant during the study.

Where it is running

• Taro Pharmaceuticals USA, Inc. — Hawthorne, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.